Finally, we examined the protein expression of IRF3 in tumor tissues from 122 glioma patients, and found that the relative IRF3 expression was significantly lower in IDH1mut gliomas compared with IDH1wt gliomas (Fig. 4m). This evidence concerns the gene IRF3 and central nervous system cancer.